A medication use evaluation (MUE) is a systematic review that hospitals and health systems use to determine whether a specific medication is being prescribed, dispensed, and administered appropriately. It functions as a performance measurement tool that audits how a drug moves through every stage of patient care, from the initial prescribing decision to the final clinical outcome. The Joint Commission, which accredits U.S. hospitals, requires facilities to evaluate the effectiveness of their medication management systems, and MUEs are one of the primary ways hospitals meet that standard.
How MUEs Differ From Drug Utilization Reviews
You may see the terms “medication use evaluation,” “drug utilization review” (DUR), and “drug use evaluation” (DUE) used interchangeably, but there is a meaningful distinction. Traditional DUR and DUE programs tend to focus narrowly on whether a specific drug is being used correctly at the individual patient level: right dose, right indication, right duration. An MUE goes further. It takes a multidisciplinary, outcomes-focused approach, assessing not just whether the drug was prescribed correctly but whether patients actually got better as a result. The overarching goal is optimizing patient outcomes and quality of life, not simply checking boxes on a prescribing checklist.
In practice, this means an MUE might examine the entire process surrounding a medication: how it’s ordered, how it’s prepared in the pharmacy, how nurses administer it, and what happens to the patient afterward. A DUR might flag that a patient received the wrong dose. An MUE asks why the wrong dose was ordered in the first place and what system-level changes could prevent it from happening again.
Which Medications Get Selected for Review
Hospitals don’t evaluate every medication on their formulary. Instead, they target drugs that meet certain risk criteria. A medication or medication-use process typically gets selected for an MUE when it falls into one or more of these categories:
- High risk: The drug carries a significant chance of serious adverse effects, dangerous interactions with other medications or foods, or a narrow margin between a therapeutic dose and a toxic one.
- High volume: The medication is used frequently enough that even small prescribing errors could affect many patients.
- High cost: Expensive drugs, particularly newer biologics or specialty medications, warrant scrutiny to ensure they’re being used for appropriate indications and not being wasted.
- Problem-prone: The drug or the process surrounding it has already generated medication errors, cases of toxicity, or a pattern of pharmacist interventions that suggest something is going wrong.
- High-risk population: The medication is being used in vulnerable groups such as critically ill patients, neonates, or elderly patients where the consequences of misuse are amplified.
Specific triggers can also prompt a review. A spike in adverse drug reactions, frequent non-formulary use requests, or a cluster of medication errors involving a particular drug can all signal that an MUE is needed.
Common Drug Classes Targeted for MUEs
Antibiotics are one of the most frequently evaluated drug classes. Antimicrobial MUEs are a cornerstone of hospital antibiotic stewardship programs, which aim to reduce unnecessary antibiotic use and slow the development of resistant bacteria. These evaluations can focus on a single antibiotic, an entire class, or the treatment approach for a specific infection. A hospital might review whether broad-spectrum antibiotics are being narrowed to targeted therapy once culture results come back, or whether surgical patients are receiving prophylactic antibiotics within the recommended time window.
Beyond antibiotics, anticoagulants (blood thinners) are frequent MUE targets because dosing errors can cause life-threatening bleeding or fail to prevent clots. Opioids, high-alert medications like insulin, and expensive specialty drugs such as monoclonal antibodies also commonly undergo evaluation.
Who Conducts the Evaluation
MUEs are not a solo effort by the pharmacy department. They involve a multidisciplinary team, and the Pharmacy and Therapeutics (P&T) committee plays a central coordinating role. P&T committees evaluate the clinical use of medications and develop policies for managing access to them, ensuring safe and effective drug use across the institution. These committees typically include pharmacists, physicians, and nurses, and increasingly draw on expertise from other professionals like data analysts.
Pharmacists often lead the data collection and analysis because they have direct visibility into prescribing patterns, dispensing records, and drug interactions. Physicians contribute clinical judgment about whether prescribing decisions align with current evidence-based guidelines. Nurses, who are the last checkpoint before a medication reaches the patient, provide critical insight into administration practices, patient responses, and real-world obstacles that may not be visible from a prescription alone. Their hands-on experience helps the committee understand cost, safety, and quality issues from the bedside perspective.
How the MUE Process Works
The process follows a structured cycle. First, the team selects a medication or medication-use process based on the criteria described above. They then establish specific, measurable standards against which prescribing and outcomes will be judged. These criteria are drawn from clinical practice guidelines, FDA-approved labeling, and published evidence.
Next comes data collection. The team pulls patient records over a defined time period and evaluates each case against the established criteria. They might look at whether the drug was prescribed for an approved indication, whether the dose was appropriate for the patient’s kidney function, whether required lab monitoring was completed on schedule, or whether the patient experienced the intended clinical improvement.
Once the data are analyzed, the team identifies gaps between actual practice and ideal practice. If the evaluation reveals that only 60% of patients are receiving the correct initial dose of an antibiotic, for example, the team develops an action plan. This might include updating order sets in the electronic health record, creating prescriber education materials, or implementing pharmacy-driven dosing protocols. The cycle then repeats: the hospital conducts a follow-up MUE after the intervention to see if practice actually improved.
What MUEs Measure
The metrics in an MUE typically fall into three categories. Process measures look at whether the right steps happened: Was the drug prescribed at the correct dose? Was baseline lab work ordered? Was the patient switched from an IV to an oral formulation when appropriate? Clinical outcome measures assess whether patients improved: Did the infection resolve? Did the blood clot dissolve? Did the patient avoid a preventable adverse reaction? Economic measures track the financial impact: Did formulary compliance reduce spending? Did shorter courses of therapy lower drug costs without compromising outcomes?
A well-designed MUE connects all three. Improving a process measure (like ensuring timely antibiotic dosing) should lead to better clinical outcomes (faster infection resolution) and often produces economic benefits as well (shorter hospital stays).
Why MUEs Matter for Patient Care
The fundamental purpose of an MUE is to improve health care outcomes and, ultimately, patients’ quality of life through optimal medication therapy. Hospitals use thousands of medications, and even well-trained clinicians can develop prescribing habits that drift away from best practices over time. New evidence emerges, guidelines change, and institutional memory fades. MUEs create a systematic check against that drift.
They also create accountability. Because MUE results are reported to P&T committees and hospital leadership, they make prescribing patterns visible in a way that informal feedback cannot. When data show that a specific practice is falling short, it becomes much harder to ignore. The result is a continuous improvement loop where hospitals identify problems, implement changes, and verify that those changes actually worked, one medication at a time.